Finance

Lists
Why is CHRS up ၃.၈၈%?
Dive Deeper
CHRS:NASDAQ
Coherus Oncology Inc
၁.၀၇ US$
+၃.၈၈%
(+၀.၀၄၀) 1D
၁.၀၆ US$
-၀.၉၃% (-၀.၀၁၀)
Pre-market
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
၁.၀၆ US$
High
၁.၀၈ US$
Low
၁.၀၀ US$
Mkt. cap
၁၆.၅၃ ကုဋေ
Avg. vol.
၁.၄၀ သန်း
Volume
၄၅၂.၀၀
52-wk high
၂.၆၂ US$
52-wk low
၀.၉၇ US$
EPS
-၁.၀၃ US$
Beta
၀.၉၈
Shares outstanding
၁၅.၄၅ ကုဋေ
No. of employees
၁၄၄
Open
၁.၀၆ US$
High
၁.၀၈ US$
Low
၁.၀၀ US$
Mkt. cap
၁၆.၅၃ ကုဋေ
Avg. vol.
၁.၄၀ သန်း
Volume
၄၅၂.၀၀
52-wk high
၂.၆၂ US$
52-wk low
၀.၉၇ US$
EPS
-၁.၀၃ US$
Beta
၀.၉၈
Shares outstanding
၁၅.၄၅ ကုဋေ
No. of employees
၁၄၄
News stories
From web sources and news partners
StockStory
StockStory
·
ပြီးခဲ့သည့် ၉ မိနစ်
1 S&P 500 Stock with Competitive Advantages and 2 We Brush Off
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
X-Energy (NASDAQ:XE) Reaches New 12-Month Low - Time to Sell?
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Dow Futures Rise; ASML Earnings Beat, CPI Inflation Due
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
About Coherus Oncology Inc
CEODennis Lanfear
Employees၁၄၄
Founded၂၀၁၀
HeadquartersRedwood City, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CHRS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current ၁.၀၇ US$
၁၀.၀၀ US$ (+၈၃၄.၅၈%)
Average
၇.၇၅ US$ (+၆၂၄.၃၀%)
Lowest
၄.၀၀ US$ (+၂၇၃.၈၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
၇.၀၀ US$
+၅၅၄.၂%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
၄.၀၀ US$
+၂၇၃.၈%
08/06/2026
Paul Jeng
Guggenheim
Buy
Maintained
၁၀.၀၀ US$
+၈၃၄.၆%
08/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
၁၀.၀၀ US$
+၈၃၄.၆%
08/06/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
-
-
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၁၆ ကုဋေ
၁.၂၇ ကုဋေ
၁.၂၃ ကုဋေ
၁.၄၃ ကုဋေ
Cost of goods sold
၃.၇၂ သန်း
၄.၀၄ သန်း
၃.၈၁ သန်း
၄.၂၄ သန်း
Cost of revenue
၃.၇၂ သန်း
၄.၀၄ သန်း
၃.၈၁ သန်း
၄.၂၄ သန်း
Research and development expenses
၂.၇၃ ကုဋေ
၃.၁၀ ကုဋေ
၂.၁၅ ကုဋေ
၂.၁၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၂၈ ကုဋေ
၂.၁၀ ကုဋေ
၂.၃၁ ကုဋေ
၂.၁၀ ကုဋေ
Operating expense
၅.၀၁ ကုဋေ
၅.၂၀ ကုဋေ
၄.၄၆ ကုဋေ
၄.၂၄ ကုဋေ
Total operating expenses
၅.၃၈ ကုဋေ
၅.၆၀ ကုဋေ
၄.၈၅ ကုဋေ
၄.၆၆ ကုဋေ
Operating income
-၄.၂၂ ကုဋေ
-၄.၃၃ ကုဋေ
-၃.၆၂ ကုဋေ
-၃.၂၃ ကုဋေ
Other non operating income
၂.၁၄ သန်း
-၅.၂၂ သန်း
၁.၄၀ သန်း
၁.၃၁ သန်း
EBT including unusual items
-၄.၄၅ ကုဋေ
-၄.၆၃ ကုဋေ
-၃.၆၉ ကုဋေ
-၃.၃၃ ကုဋေ
EBT excluding unusual items
-၄.၂၄ ကုဋေ
-၄.၃၇ ကုဋေ
-၃.၆၉ ကုဋေ
-၃.၃၃ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၃.၅၅ ကုဋေ
-၃.၇၆ ကုဋေ
-၃.၈၃ ကုဋေ
-၂.၀၆ ကုဋေ
Net profit margin
-၃၀၇.၀၇%
-၂၉၅.၂၉%
-၃၁၁.၃၅%
-၁၄၄.၂၀%
Earnings per share
-၀.၃၃
-၀.၃၄
-၀.၂၅
-၀.၁၉
Interest and investment income
-
၇.၀၀ သန်း
-
-
Interest expense
-၂.၃၂ သန်း
-၂.၂၅ သန်း
-၂.၁၉ သန်း
-၂.၃၂ သန်း
Net interest expenses
-၂.၃၂ သန်း
၄.၇၅ သန်း
-၂.၁၉ သန်း
-၂.၃၂ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၁၃ ကုဋေ
-၄.၂၄ ကုဋေ
-၃.၅၃ ကုဋေ
-၃.၁၅ ကုဋေ
Gain or loss from assets sale
-
-၃၃.၈၃ ကုဋေ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ